Baker & McKenzie has chosen Singapore partner Ashok Lalwani to head the firm’s global India practice. He succeeds David Jacobs, who led the practice since 2005 and is retiring as a partner of the firm.
Baker & McKenzie’s India practice includes over 300 lawyers worldwide, who advise Indian companies on outbound matters and multinational entities on their investments in India. Lalwani will spearhead this group.
The firm has won important India mandates over the years including as an adviser on Abbott Laboratories’ US$3.8 billion acquisition of Piramal Healthcare; Hospira and a subsidiary’s US$200 million acquisition of Orchid Chemicals & Pharmaceuticals’ active pharmaceutical ingredient manufacturing facility; and Coal India’s acquisition of a coal mine in Indonesia.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
